{"id":545797,"date":"2025-11-05T12:06:09","date_gmt":"2025-11-05T16:06:09","guid":{"rendered":"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid="},"modified":"2025-11-05T12:10:09","modified_gmt":"2025-11-05T16:10:09","slug":"diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2","status":"publish","type":"product","link":"https:\/\/www.mdbriefcase.com\/fr\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=","title":{"rendered":"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne?"},"content":{"rendered":"<p dir=\"ltr\" style=\"text-align: left;\">Dans ce vid\u00e9oclip, le D<sup>r<\/sup> Ron Goldenberg, un endocrinologue chez <em>LMC Diabetes and Endocrinology<\/em>, parle du paysage changeant des traitements de premi\u00e8re ligne pour le diab\u00e8te de type 2. Il passe en revue le r\u00f4le historique qu\u2019a jou\u00e9 la metformine, l\u2019impact de certaines \u00e9tudes-pivot comme la <em>UK Prospective Diabetes Study<\/em> et il explore les bienfaits potentiels des agents plus r\u00e9cents que sont les inhibiteurs du SGLT2 et les agonistes des r\u00e9cepteurs du GLP-1, en soulignant les approches th\u00e9rapeutiques individualis\u00e9es bas\u00e9es sur les profils et les affections comorbides des patients.<\/p>","protected":false},"excerpt":{"rendered":"<p>Dans ce vid\u00e9oclip, le Dr Ron Goldenberg, un endocrinologue chez LMC Diabetes and Endocrinology, parle du paysage changeant des traitements de premi\u00e8re ligne pour le diab\u00e8te de type 2. Il passe en revue le r\u00f4le historique qu\u2019a jou\u00e9 la metformine, l\u2019impact de certaines \u00e9tudes-pivot comme la UK Prospective Diabetes Study et il explore les bienfaits [&hellip;]<\/p>\n","protected":false},"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"product_brand":[],"product_cat":[],"product_tag":[],"class_list":{"0":"post-545797","1":"product","2":"type-product","3":"status-publish","6":"first","7":"instock","8":"downloadable","9":"virtual","10":"taxable","11":"purchasable","12":"product-type-simple"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne? - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne? - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Dans ce vid\u00e9oclip, le Dr Ron Goldenberg, un endocrinologue chez LMC Diabetes and Endocrinology, parle du paysage changeant des traitements de premi\u00e8re ligne pour le diab\u00e8te de type 2. Il passe en revue le r\u00f4le historique qu\u2019a jou\u00e9 la metformine, l\u2019impact de certaines \u00e9tudes-pivot comme la UK Prospective Diabetes Study et il explore les bienfaits [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-05T16:10:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=\",\"url\":\"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=\",\"name\":\"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne? - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"datePublished\":\"2025-11-05T16:06:09+00:00\",\"dateModified\":\"2025-11-05T16:10:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop &#8211; Old\",\"item\":\"https:\/\/www.mdbriefcase.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne? - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=","og_locale":"fr_CA","og_type":"article","og_title":"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne? - MDBriefCase","og_description":"Dans ce vid\u00e9oclip, le Dr Ron Goldenberg, un endocrinologue chez LMC Diabetes and Endocrinology, parle du paysage changeant des traitements de premi\u00e8re ligne pour le diab\u00e8te de type 2. Il passe en revue le r\u00f4le historique qu\u2019a jou\u00e9 la metformine, l\u2019impact de certaines \u00e9tudes-pivot comme la UK Prospective Diabetes Study et il explore les bienfaits [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=","og_site_name":"MDBriefCase","article_modified_time":"2025-11-05T16:10:09+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=","url":"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=","name":"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne? - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"datePublished":"2025-11-05T16:06:09+00:00","dateModified":"2025-11-05T16:10:09+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid="]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/product\/diabete-de-type-2-et-pharmacotherapie-la-metformine-est-elle-toujours-le-traitement-de-premiere-ligne-2\/?courseid=#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Shop &#8211; Old","item":"https:\/\/www.mdbriefcase.com\/shop\/"},{"@type":"ListItem","position":3,"name":"Diab\u00e8te de Type 2 et pharmacoth\u00e9rapie : La metformine est-elle toujours le traitement de premi\u00e8re ligne?"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product\/545797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=545797"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=545797"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=545797"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=545797"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=545797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}